All data are based on the daily closing price as of November 11, 2026
b
BioNote
377740.KO
3.41 USD
-0.12
-3.40%
Overview
Last close
3.41 usd
Market cap
344.33M usd
52 week high
4.47 usd
52 week low
2.84 usd
Target price
4.27 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
3.7202
Price/Book Value
0.3075
Enterprise Value
83.71M usd
EV/Revenue
0.8841
EV/EBITDA
1.6918
Key financials
Revenue TTM
94.69M usd
Gross Profit TTM
53.48M usd
EBITDA TTM
22.86M usd
Earnings per Share
-0.93 usd
Dividend
0.17 usd
Total assets
1.04B usd
Net debt
N/A usd
About
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.